Addition of Dexmedetomidine to Ropivacaine-induced Supraclavicular Block (ADRIB Trial)

NCT02630290 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Radius Fractures
Ulna Fractures
Hand Injuries
Wrist Injuries
Forearm Injuries

Interventions

DRUG: Ropivacaine
DRUG: Ropivacaine + Dexmedetomidine

Sponsor

Guangzhou First People's Hospital